Arrowgrass Capital Partners (US)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,224
| Closed | -$1.08M | – | 31 |
|
|
2019
Q3 | $1.08M | Sell |
21,224
-12,471
| -37% | -$632K | 0.08% | 68 |
|
|
2019
Q2 | $1.53M | Buy |
33,695
+5,496
| +19% | +$249K | 0.04% | 177 |
|
|
2019
Q1 | $1.35M | Buy |
+28,199
| New | +$1.35M | 0.04% | 160 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 144 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 239 |
|
|
2017
Q3 | – | Sell |
-51,566
| Closed | -$2.87M | – | 288 |
|
|
2017
Q2 | $2.87M | Sell |
51,566
-16,723
| -24% | -$932K | 0.02% | 214 |
|
|
2017
Q1 | $3.71M | Buy |
+68,289
| New | +$3.71M | 0.04% | 175 |
|
|
2016
Q4 | – | Sell |
-3,265
| Closed | -$176K | – | 236 |
|
|
2016
Q3 | $176K | Buy |
3,265
+2,504
| +329% | +$135K | ﹤0.01% | 206 |
|
|
2016
Q2 | $56K | Sell |
761
-550
| -42% | -$40.5K | ﹤0.01% | 202 |
|
|
2016
Q1 | $84K | Sell |
1,311
-11,042
| -89% | -$707K | ﹤0.01% | 195 |
|
|
2015
Q4 | $850K | Sell |
12,353
-7,363
| -37% | -$507K | 0.01% | 146 |
|
|
2015
Q3 | $1.17M | Buy |
+19,716
| New | +$1.17M | 0.02% | 157 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 256 |
|
|
2015
Q1 | – | Sell |
-231,998
| Closed | -$13.7M | – | 223 |
|
|
2014
Q4 | $13.7M | Buy |
+231,998
| New | +$13.7M | 0.24% | 42 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 184 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 131 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 151 |
|